NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
-1.97%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$2.1B
AUM Growth
+$2.1B
(+3.3%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
64.85%
Holding
56
New
2
Increased
9
Reduced
13
Closed
4
Top Buys
| 1 |
Cable One
CABO
|
$30.3M |
| 2 |
Corcept Therapeutics
CORT
|
$20.5M |
| 3 |
Salesforce
CRM
|
$14.4M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$10.3M |
| 5 |
Kezar Life Sciences
KZR
|
$5.15M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$67.6M |
| 2 |
Nkarta
NKTX
|
$17.9M |
| 3 |
Brookfield
BN
|
$16.9M |
| 4 |
Arcellx
ACLX
|
$15.5M |
| 5 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$12.3M |
Sector Composition
| 1 | Healthcare | 51.95% |
| 2 | Technology | 13.97% |
| 3 | Financials | 4.89% |
| 4 | Communication Services | 3.25% |
| 5 | Consumer Discretionary | 1.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard Total Stock Market ETF
VTI
$521B
| $501M | 23.88% |
1,525,550
| – | – |
|
2
Stryker
SYK
$149B
| $161M | 7.7% |
796,941
| – | – |
|
|
CTLT
3
DELISTED
CATALENT, INC.
CTLT
| $118M | 5.63% |
1,632,878
| – | – |
|
|
4
Brookfield
BN
$98.5B
| $103M | 4.89% |
2,508,830
-412,341
| -14% | -$16.9M |
|
5
ASML
ASML
$285B
| $94.2M | 4.49% |
226,770
+11,770
| +5% | +$4.89M |
|
|
6
Corcept Therapeutics
CORT
$7.46B
| $85.3M | 4.07% |
3,327,768
+801,278
| +32% | +$20.5M |
|
|
7
Salesforce
CRM
$241B
| $83.2M | 3.97% |
578,500
+100,000
| +21% | +$14.4M |
|
8
Steris
STE
$23.9B
| $77.8M | 3.71% |
467,687
| – | – |
|
|
9
Boston Scientific
BSX
$158B
| $68.3M | 3.26% |
1,762,942
-1,745,846
| -50% | -$67.6M |
|
|
10
Cable One
CABO
$900M
| $68.3M | 3.25% |
80,023
+35,550
| +80% | +$30.3M |
|
11
Apple
AAPL
$3.4T
| $63.8M | 3.04% |
461,379
| – | – |
|
|
12
Arcellx
ACLX
$3.88B
| $59.9M | 2.86% |
3,191,878
-825,000
| -21% | -$15.5M |
|
13
Edgewise Therapeutics
EWTX
$1.58B
| $59.7M | 2.85% |
6,071,703
+484,496
| +9% | +$4.77M |
|
14
TSMC
TSM
$1.18T
| $48.7M | 2.32% |
710,780
| – | – |
|
15
Alibaba
BABA
$328B
| $40.1M | 1.91% |
500,827
| – | – |
|
16
Mirum Pharmaceuticals
MIRM
$3.75B
| $35.4M | 1.69% |
1,684,193
-343,131
| -17% | -$7.21M |
|
|
VERV
17
DELISTED
Verve Therapeutics
VERV
| $31.3M | 1.49% |
911,111
-15,989
| -2% | -$549K |
|
18
BioMarin Pharmaceuticals
BMRN
$11.3B
| $26.9M | 1.28% |
317,500
| – | – |
|
19
Amicus Therapeutics
FOLD
$2.38B
| $21.9M | 1.05% |
2,100,000
-535,000
| -20% | -$5.59M |
|
|
BPMC
20
DELISTED
Blueprint Medicines
BPMC
| $20.9M | 0.99% |
316,674
| – | – |
|
|
VECT
21
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $20M | 0.96% |
3,339,484
| – | – |
|
22
Alnylam Pharmaceuticals
ALNY
$59.3B
| $20M | 0.95% |
100,000
+15,200
| +18% | +$3.04M |
|
23
Vaxcyte
PCVX
$4.09B
| $19.8M | 0.94% |
823,705
| – | – |
|
24
Milestone Pharmaceuticals
MIST
$155M
| $18.4M | 0.88% |
2,000,000
-530,003
| -21% | -$4.87M |
|
|
UTRS
25
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $17.2M | 0.82% |
1,862,877
-186,015
| -9% | -$1.72M |
|